Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of GST-tagged human recombinant HCK expressed in insect cells at 200 nM by Z'-lyte assay
Assay data:1 Tested
SummaryRelated BioAssays by Target
Inhibition of HCK (unknown origin) by Z'LYTE assay
Assay data:2 Active, 1 Activity ≤ 1 µM, 2 Tested
Inhibition of HCK (unknown origin) incubated for 1 hr in presence of ATP by Z'LYTE assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Selectivity interaction (Z?-LYTE assay) EUB0000638a HCK
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000147b HCK
Inhibition of recombinant Hck (unknown origin)
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of Nef activated HCK (unknown origin)
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of HCK (unknown origin)
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
HCK DiscoveRx kinase panel
Hck(h) activated Kinase panel
Hck(h) Kinase panel
Inhibition of HCK (unknown origin) at 1 uM
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of human recombinant Hck assessed as reduction in substrate phosphorylation at 50 to 500 nM using ATP and Ulight-CKKSRGDYMTMQIG (IRS-1) incubated for 60 min by LANCE detection method
Protein Kinase Assay from US Patent US10975058: "Imidazolyl kinase inhibitors and uses thereof"
Assay data:4 Active, 2 Activity ≤ 1 µM, 4 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibition Assay from US Patent US10844077: "Thiazolyl-containing compounds for treating proliferative diseases"
Assay data:20 Active, 8 Activity ≤ 1 nM, 18 Activity ≤ 1 µM, 22 Tested
Biological Activity Assay from US Patent US10844038: "1,2-dithiolane compounds useful in neuroprotection, autoimmune and cancer diseases and conditions"
Assay data:5 Active, 5 Activity ≤ 1 µM, 5 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Kinase Selectivity Assay from US Patent US10711006: "Selective Bruton's tyrosine kinase inhibitor and use thereof"
Assay data:5 Active, 1 Activity ≤ 1 nM, 5 Activity ≤ 1 µM, 5 Tested
In Vitro Activity Assay from US Patent US10633348: "Methods to treat lymphoplasmacytic lymphoma"
Assay data:14 Active, 12 Activity ≤ 1 µM, 16 Tested
In Vitro Activity Assay from US Patent US10597387: "Methods to treat lymphoplasmacytic lymphoma"
Assay data:8 Active, 8 Activity ≤ 1 µM, 8 Tested
luminescent kinase assay from US Patent US10544104: "Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases"
Assay data:129 Active, 6 Activity ≤ 1 nM, 112 Activity ≤ 1 µM, 141 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on